IL6 and obesity disorder: Obesity is commonly accompanied with low-grade systemic inflammation which is a key driver of the subsequent comorbidities of obesity due to higher concentrations of endotoxic molecules (i.e., LPS from bacteria) and in circulation increased adiposity increasing cytokines such as TNF-α, IL-1, and IL-6 (138, 139).